Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-04 Sale | 2026-06-05 4:28 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Executive Officer | 34,273 | $17.93 | $614,635 | 459,520 (Direct) | View |
| 2026-06-02 Sale | 2026-06-03 4:54 pm | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 2,945 | $15.77 | $46,445 | 89,499 (Direct) | View |
| 2026-06-02 Sale | 2026-06-03 4:53 pm | NovoCure Ltd | NVCR | Stafford Kristin Director | 2,945 | $15.77 | $46,445 | 11,324 (Direct) | View |
| 2026-06-02 Sale | 2026-06-03 4:53 pm | NovoCure Ltd | NVCR | Ocean Allyson J Director | 2,945 | $15.77 | $46,445 | 11,324 (Direct) | View |
| 2026-06-02 Sale | 2026-06-03 4:53 pm | NovoCure Ltd | NVCR | Scannell Timothy J Director | 2,945 | $15.77 | $46,445 | 14,288 (Direct) | View |
| 2026-06-02 Sale | 2026-06-03 4:53 pm | NovoCure Ltd | NVCR | HILLEMAN JERYL L Director | 2,945 | $15.77 | $46,445 | 13,861 (Direct) | View |
| 2026-06-02 Sale | 2026-06-03 4:52 pm | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 2,945 | $15.77 | $46,445 | 197,657 (Direct) | View |
| 2026-06-02 Sale | 2026-06-03 4:52 pm | NovoCure Ltd | NVCR | Hung David Director | 2,945 | $15.77 | $46,445 | 20,465 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 4:33 pm | NovoCure Ltd | NVCR | Leupin Nicolas Former Chief Medical Officer | 1,100 | $13.31 | $14,636 | 102,979 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 4:32 pm | NovoCure Ltd | NVCR | Weinberg Uri Chf Medical and Innovation Ofr | 6,412 | $13.31 | $85,314 | 340,530 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 4:31 pm | NovoCure Ltd | NVCR | Brackmann Christoph Chief Financial Officer | 6,412 | $13.31 | $85,314 | 263,516 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 4:31 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Executive Officer | 5,607 | $13.31 | $74,603 | 710,181 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 4:31 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 48,623 | $13.72 | $667,214 | 146,356 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 4:31 pm | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1,100 | $13.31 | $14,636 | 259,994 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 4:30 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 71,887 | $12.98 | $932,883 | 875,359 (Direct) | View |
| 2026-02-27 Sale | 2026-03-03 4:11 pm | NovoCure Ltd | NVCR | Weinberg Uri Chf Medical and Innovation Ofr | 10,733 | $13.68 | $146,863 | 223,477 (Direct) | View |
| 2026-02-27 Sale | 2026-03-03 4:10 pm | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1,441 | $13.66 | $19,690 | 162,322 (Direct) | View |
| 2026-02-27 Sale | 2026-03-03 4:10 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 1,963 | $13.63 | $26,752 | 76,343 (Direct) | View |
| 2026-02-27 Sale | 2026-03-03 4:09 pm | NovoCure Ltd | NVCR | Leupin Nicolas Former Chief Medical Officer | 1,029 | $13.66 | $14,060 | 104,079 (Direct) | View |
| 2026-02-27 Sale | 2026-03-03 4:09 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Executive Officer | 16,966 | $13.59 | $230,585 | 349,400 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-03 Option Award | 2026-06-05 4:27 pm | 2027-06-03 2036-06-03 | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 28,609 | $0 | 118,108 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:27 pm | 2027-06-03 2036-06-03 | NovoCure Ltd | NVCR | Stafford Kristin Director | 28,609 | $0 | 39,933 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:27 pm | 2027-06-03 2036-06-03 | NovoCure Ltd | NVCR | Ocean Allyson J Director | 28,609 | $0 | 39,933 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:26 pm | 2027-06-03 2036-06-03 | NovoCure Ltd | NVCR | Scannell Timothy J Director | 28,609 | $0 | 42,897 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:26 pm | 2027-06-03 2036-06-03 | NovoCure Ltd | NVCR | HILLEMAN JERYL L Director | 28,609 | $0 | 42,470 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:26 pm | 2027-06-03 2036-06-03 | NovoCure Ltd | NVCR | Hung David Director | 28,609 | $0 | 49,074 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:26 pm | 2027-06-03 2036-06-03 | NovoCure Ltd | NVCR | Madden Martin J. Director | 28,609 | $0 | 47,283 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-05 4:25 pm | 2027-06-03 2036-06-03 | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 28,609 | $0 | 226,266 (Direct) | View |
| 2026-04-28 Exercise | 2026-04-28 4:27 pm | N/A N/A | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 21,500 | $11.39 | 200,602 (Direct) | View |
| 2026-04-28 Exercise | 2026-04-28 4:27 pm | 2017-05-04 2026-05-04 | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 21,500 | $0 | 200,602 (Direct) | View |
| 2026-03-04 Tax Withholding | 2026-03-05 4:33 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Former Chief Executive Officer | 17,638 | $13.3 | 422,570 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 4:32 pm | N/A 2036-03-03 | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 123,465 | $0 | 315,793 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 4:32 pm | N/A 2036-03-03 | NovoCure Ltd | NVCR | Weinberg Uri Chf Medical and Innovation Ofr | 123,465 | $0 | 340,530 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 4:31 pm | N/A 2036-03-03 | NovoCure Ltd | NVCR | Brackmann Christoph Chief Financial Officer | 135,811 | $0 | 263,516 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 4:31 pm | N/A 2036-03-03 | NovoCure Ltd | NVCR | Leonard Frank X Chief Executive Officer | 366,388 | $0 | 710,181 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 4:31 pm | N/A 2036-03-03 | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 111,118 | $0 | 146,356 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 4:31 pm | N/A 2036-03-03 | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 98,772 | $0 | 259,994 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 4:30 pm | N/A 2036-03-03 | NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman | 688,801 | $0 | 875,359 (Direct) | View |
| 2026-02-28 Option Award | 2026-03-03 4:11 pm | N/A N/A | NovoCure Ltd | NVCR | Weinberg Uri Chf Medical and Innovation Ofr | 12,992 | $0 | 223,477 (Direct) | View |
| 2026-02-28 Option Award | 2026-03-03 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Executive Officer | 18,621 | $0 | 349,400 (Direct) | View |
| 2026-02-28 Option Award | 2026-03-03 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Former Chief Executive Officer | 23,818 | $0 | 440,208 (Direct) | View |
| 2026-02-27 Tax Withholding | 2026-03-03 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Former Chief Executive Officer | 11,541 | $13.75 | 440,208 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Former Chief Executive Officer | 9,638 | $13.67 | 440,208 (Direct) | View |
| 2026-02-28 Option Award | 2026-03-03 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 17,755 | $0 | 192,328 (Direct) | View |
| 2026-01-11 Tax Withholding | 2026-01-12 5:30 pm | N/A N/A | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 2,133 | $14.35 | 78,306 (Direct) | View |
| 2025-12-31 Ownership | 2026-01-08 4:22 pm | N/A N/A | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1 | $10.99 | 163,763 (Direct) | View |
| 2025-12-31 Ownership | 2026-01-08 4:21 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Director | 1 | $10.99 | 416,474 (Direct) | View |
| 2025-12-31 Ownership | 2026-01-08 4:21 pm | N/A N/A | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 108 | $10.99 | 174,573 (Direct) | View |
| 2025-11-04 Tax Withholding | 2025-11-04 4:10 pm | N/A N/A | NovoCure Ltd | NVCR | Brackmann Christoph Chief Financial Officer | 7,033 | $12.23 | 134,117 (Direct) | View |
| 2025-11-01 Tax Withholding | 2025-11-04 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 168 | $12.81 | 80,439 (Direct) | View |
| 2025-11-04 Tax Withholding | 2025-11-04 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 2,949 | $12.23 | 80,439 (Direct) | View |
| 2025-11-01 Tax Withholding | 2025-11-04 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 966 | $12.81 | 347,745 (Direct) | View |